About
Adam Cotton is a Principal at the Novartis Venture Fund. Before joining the firm, he conducted antibody engineering research in the labs of Jim Wells and Ian Seiple, and he is a scientific co-founder of Epi Biologics who also contributed to establishing Rezo Therapeutics and HYKU Biosciences as they emerged from academic labs. He holds a BA in Chemistry from Harvard University, an MBA from the University of New Mexico, and a PhD in Chemistry & Chemical Biology from the University of California, San Francisco.
Invests in
Biotech
Experience
- Novartis Venture FundPrincipalcurrent2025 β presentCambridge, Massachusetts, United States
- Novartis Venture FundAssociate2023 β 2025Cambridge, Massachusetts, United States
- Novartis Venture FundAnalyst2022 β 2023Cambridge, Massachusetts, United States
- Mediar TherapeuticsBoard Directorcurrent2022 β present
- Protego BioBoard Observercurrent2025 β present
- GentiBioBoard Observercurrent2023 β present
- ONL TherapeuticsBoard Observer2024 β 2026
- Hyku BiosciencesBoard Observer2023 β 2026
- FoRx TherapeuticsBoard Observer2022 β 2023
- EpiBiologicsCo-Founder2021 β 2022
- RA Capital Management, L.P.Consultant2021 β 2022
- University of California, San FranciscoPhD candidate2017 β 2021San Francisco Bay Area
- UCSF Innovation VenturesTechnology Analyst2020 β 2021San Francisco, California, United States
- The University of New MexicoChemistry Tutor2016 β 2017
- The University of New MexicoTrack and Field Athlete2015 β 2017
- Harvard Extension SchoolTeaching Fellow2015
- Harvard UniversityResearch assistant2013 β 2015
- Harvard UniversityPeer Tutor2013 β 2015
- Harvard UniversityTrack and Field Athlete2011 β 2015
- Harvard Extention SchoolTeaching Fellow2014
Education
- University of California, San FranciscoDoctor of Philosophy - PhD, Chemistry and Chemical Biology2017 β 2021
- UNM The James & Gail Ellis School of Business LeadershipMaster of Business Administration (M.B.A.), General Management2015 β 2017
- Harvard UniversityA.B, Chemistry2011 β 2015
Skills & more
PythonChemical Biology1antibody engineeringChemistry3Research3Organic Chemistry2Organic Synthesis1R&D1NMR1Mass Spectrometry2UV/Vis1Spectroscopy1
+2 more
Inorganic ChemistryMolecular OncologyLanguages English
From Adam's professional profile.
Same school
Also attended University of California, San Francisco40
Douglas CrawfordManaging General Partner at Mission BiocapitalMatt MaurerInvestor at WVV CapitalAlec NielsenFounder & CEO, Asimov & Venture Partner at Pillar VCHarlan LevinePresident of Health Innovation and Policy at Oncology VenturesKatarina PancePrincipal at SR One Capital ManagementDr. Jay GuptaVenture Partner at Boutique Venture Partners
+ 34 more
Also attended UNM The James & Gail Ellis School of Business Leadership3
Also attended Harvard University1,171
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,165 more
Shared employers
Also worked at Mediar Therapeutics5
Also worked at ONL Therapeutics1
Also worked at FoRx Therapeutics1
Also worked at University of California, San Francisco47
Logan HilleLife Sciences Analyst at CincyTechDavid KaufmanInvestor at Third Rock VenturesFrancisco GimenezInvestment Team at 8VCHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersMichael FischbachBio Advisor at Amplify PartnersDr. ChettipallyVenture Advisor at Think+ Ventures Management, Llc
+ 41 more
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja KΓΆnig
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Network3
Mo KoyfmanScout
Founder and General Partner at Shine Capital
Ronny ConwayScout
Managing Partner at SV Angel
Dyson Bogg
Investor at Mercuri.vc
Investors connected to Adam in public investor directories β a warm-intro map.


































